Paradoxical elevation of plasma dabigatran after reversal with idarucizumab in stroke thrombolysis

被引：7
|
作者：
Hosoki, Satoshi [1 ]
Takagi, Masahito [1 ]
Yamagami, Hiroshi [2 ]
Ando, Daisuke [1 ]
Toyoda, Kazunori [1 ]
Koga, Masatoshi [1 ]
机构：
[1] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan
[2] Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, Suita, Osaka, Japan
来源：
JOURNAL OF NEUROLOGY | 2018年 / 265卷 / 10期
关键词：
D O I：
10.1007/s00415-018-9011-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：2451 / 2453
页数：3
相关论文
共 50 条
  • [31] Reversal of Dabigatran with Idarucizumab
    Sodha, Neel R.
    Sellke, Frank W.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (08) : 889 - 893
  • [32] Idarucizumab for the Reversal of Dabigatran
    Gottlieb, Michael
    Khishfe, Basem
    ANNALS OF EMERGENCY MEDICINE, 2017, 69 (05) : 554 - 558
  • [33] Idarucizumab for Dabigatran Reversal
    Pollack, Charles V., Jr.
    Reilly, Paul A.
    Eikelboom, John
    Glund, Stephan
    Verhamme, Peter
    Bernstein, Richard A.
    Dubiel, Robert
    Huisman, Menno V.
    Hylek, Elaine M.
    Kamphuisen, Pieter W.
    Kreuzer, Jrg
    Levy, Jerrold H.
    Sellke, Frank W.
    Stangier, Joachim
    Steiner, Thorsten
    Wang, Bushi
    Kam, Chak-Wah
    Weitz, Jeffrey I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (06): : 511 - 520
  • [34] Systemic Thrombolysis for Ischemic Stroke after Antagonizing Dabigatran with Idarucizumab-A Case Report
    Schaefer, Niklas
    Mueller, Andreas
    Wuellner, Ullrich
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (08): : E126 - E127
  • [35] Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience
    Sanak, Daniel
    Jakubicek, Stanislava
    Cernik, David
    Herzig, Roman
    Kunas, Zdenek
    Mikulik, Robert
    Ostry, Svatopluk
    Reif, Michal
    Rohan, Vladimir
    Tomek, Ales
    Veverka, Tomas
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (09): : 2479 - 2483
  • [36] Successful Treatment with t-PA of a Stroke Patient after Reversal of Dabigatran with Idarucizumab
    Cossey, Tiffany
    Reddy, Sujan
    Savitz, Sean
    Grotta, James
    NEUROLOGY, 2017, 88
  • [37] Dabigatran Reversal With Idarucizumab Preceding Thrombolysis in an Octogenarian Patient with Chronic Kidney Disease and Acute Stroke: A Case Report
    Laxamana, Lina C.
    Co, Christian Oliver C.
    Yu, Jeryl Ritzi T.
    Mojica, Christianne, V
    Iboleon-Dy, Maria Adelaida M.
    Domingo, Alyssa Mae C.
    Ilano, Karen Czarina S.
    Macrohon-Valdez, Ma Cristina Z.
    CLINICAL THERAPEUTICS, 2020, 42 (09) : 1840 - 1845
  • [38] Idarucizumab The Antidote for Reversal of Dabigatran
    Eikelboom, John W.
    Quinlan, Daniel J.
    van Ryn, Joanne
    Weitz, Jeffrey I.
    CIRCULATION, 2015, 132 (25) : 2412 - 2422
  • [39] Dabigatran Reversal with Idarucizumab Reply
    Pollack, Charles V., Jr.
    Reilly, Paul A.
    Weitz, Jeffrey I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (17): : 1691 - 1692
  • [40] Incomplete dabigatran reversal with idarucizumab
    Steele, Aaron P.
    Lee, Jin A.
    Dager, William E.
    CLINICAL TOXICOLOGY, 2018, 56 (03) : 216 - 218
12345